Amerikaans biotechbedrijf Denali Therapeutics koopt licentie Alzheimeronderzoek Bart De Strooper @KU_Leuven@VIBLifeSciences over voor onbekende prijs. Doel is om nieuw geneesmiddel tegen de ziekte te ontwikkelen met eigen team.
"Every new person affected by #measles in Europe reminds us that unvaccinated children and adults, regardless of where they live, remain at risk of catching the disease and spreading it to others who may not be able to get vaccinated.” #vaccinesbbc.co.uk/news/health-431252…